Dr. Rothman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1460 Victory Boulevard
Staten Island, NY 10301Phone+1 718-442-0300- Is this information wrong?
Education & Training
- University of Pennsylvania Health SystemFellowship, Endocrinology, Diabetes, and Metabolism, 1975 - 1977
- University of Pennsylvania Health SystemResidency, Internal Medicine, 1970 - 1973
- Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1970
Certifications & Licensure
- NY State Medical License 1977 - 2025
- PA State Medical License 1971 - 1988
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Fellow (FACE) American Association of Clinical Endocrinology
- Super Doctor SuperDoctors.com
Clinical Trials
- Efficacy Study of High Dose Symlin to Treat Type 2 Diabetes Mellitus Start of enrollment: 2010 May 01
- A Registry for Participants With Chronic Hypoparathyroidism Start of enrollment: 2013 Jul 30
Publications & Presentations
PubMed
- Long-Term Safety and Efficacy of Recombinant Human Parathyroid Hormone (1-84) in Adults With Chronic Hypoparathyroidism.Nelson B Watts, John P Bilezikian, Henry G Bone, Bart L Clarke, Douglas Denham, Michael A Levine, Michael Mannstadt, Munro Peacock, Jeffrey G Rothman, Tamara J Vokes, ...> ;Journal of the Endocrine Society. 2023 Mar 6
- 36 citationsSafety and Efficacy of 5 Years of Treatment With Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism.Michael Mannstadt, Bart L. Clarke, John P. Bilezikian, Henry G. Bone, Douglas Denham, Michael A. Levine, Munro Peacock, Jeffrey Rothman, Dolores M. Shoback, Mark Warre...> ;The Journal of Clinical Endocrinology and Metabolism. 2019 Nov 1
- 14 citationsSafety and Efficacy of Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism Randomly Assigned to Receive Fixed 25-μg or 50-μg Daily Doses.John P. Bilezikian, Bart L. Clarke, Michael Mannstadt, Jeffrey Rothman, Tamara Vokes, Hak Myung Lee, Alan Krasner> ;Clinical Therapeutics. 2017 Oct 1
- Join now to see all
Professional Memberships
- Fellow
Hospital Affiliations
- Staten Island University HospitalStaten Island, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: